DYSIS Medical
- Company typePrivate
- Founded2002
- HeadquartersLivingston, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
DYSIS Medical firmographics
Firmographics- Name
- DYSIS Medical
- Legal name
- DYSIS Medical Inc.
- Website
- https://dysismedical.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Closed
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
DYSIS Medical industry classification
Industry- Product category
- Cervical Cancer Diagnostic Imaging Devices
- NAICS
- Medical Laboratories (621511)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics) (HLAHAAAE)
- akta.pro secondary industries
- Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI), Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE)
Keywords
Where DYSIS Medical is headquartered
LocationHeadquarters
- HQ city
- Livingston
- HQ country
- United Kingdom
- HQ region
- Europe
Offices5 records
Markets served
DYSIS Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Colposcope Hardware Sales: Sale of DYSIS colposcope devices (DYSIS View, DYSIS Ultra, DYSIS Classic) as capital equipment to hospitals, clinics, and healthcare systems
- Accessories and Consumables: Sales of DYSIS accessories and related products for colposcopy procedures
- Service and Maintenance: Ongoing service, training, and support for installed colposcope base
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Capital equipment pricing for DYSIS colposcope systems |
| Unit Pricing | Pay-as-you-go | Medicare reimbursement for computer-aided cervical mapping |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels8 records
DYSIS Medical product offering
Product offeringCore offering
DYSIS Medical develops and sells digital colposcope systems (DYSIS View and DYSIS Ultra) that incorporate proprietary Dynamic Spectral Imaging technology to perform computer-aided cervical mapping. The DYSISmap software quantifies acetowhitening changes during colposcopic examinations and generates a color-coded map to objectively identify areas of potential cervical lesions for biopsy guidance. The product line supports gynecologists, colposcopists, hospitals, and national cervical screening programs in detecting high-grade cervical lesions more reliably than conventional colposcopy.
Product overview
DYSIS Medical offers a portfolio of computer-aided colposcopy products built on its proprietary Dynamic Spectral Imaging System platform. The core product line consists of DYSIS View and DYSIS Ultra — FDA-cleared and CE-marked digital colposcopes that generate the DYSISmap, a color-coded cervical map quantifying acetowhitening changes to assist healthcare professionals in detecting cervical lesions, selecting biopsy sites, and documenting examinations. The DYSISmap software is the central enabling technology across all colposcope products, while DYSIS SMARTtrack adds longitudinal lesion tracking. Supporting offerings include DYSIS Accessories, the Colposcopy Skills online training platform, and DYSIS Smart Colposcopy as the branded examination procedure associated with CPT add-on code 57465.
Differentiator
Problem solved
Functional benefit
Brands
- DYSIS View: Compact and portable colposcope design with computer-aided cervical mapping (DYSISmap)
- DYSIS Ultra
- DYSISmap
- DYSIS SMARTtrack
- DYSIS Accessories
Products and services
- DYSIS View Compact and portable digital colposcope with computer-aided cervical mapping (DYSISmap), designed as an 'out of the box ready' system for ease of use in clinical settings. Captures high-resolution images and video during colposcopy examinations and generates a color-coded DYSISmap to assist healthcare professionals in detecting and documenting cervical lesions.
- DYSIS Ultra Advanced digital colposcope with computer-aided cervical mapping (DYSISmap). Incorporates the same Dynamic Spectral Imaging and color-coded mapping technology as DYSIS View, designed to help healthcare professionals detect cervical lesions efficiently, select biopsy sites, and improve exam documentation.
- DYSISmap Proprietary computer-aided cervical mapping software integral to all DYSIS Colposcopes. Quantifies acetowhitening by measuring speed, intensity, and duration of changes during examination, calculates dynamic curves, and assigns distinct colors to assist clinicians in identifying potential areas of concern for biopsy guidance, documentation, and patient education.
- DYSIS SMARTtrack Software included within DYSIS Colposcopes that allows healthcare professionals to compare a patient's DYSIS colposcopy exams over time. Tracks cervical lesions across multiple examinations and facilitates conservative management by enabling longitudinal assessment of disease progression or resolution.
- DYSIS Accessories Supporting equipment and consumables for DYSIS Colposcopes, including accessories needed for colposcopy examinations and equipment maintenance.
Quantifiable outcome
- 88% sensitivity for detecting high-grade disease when DYSISmap combined with conventional colposcopic assessment vs 55% for conventional colposcopy alone
- +5 more outcomes
Companies that use DYSIS Medical
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
DYSIS Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
DYSIS Medical partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered flagship, core, minor and standard.
- Apgar Danmark A/SflagshipEffective February 4, 2025, Apgar Danmark A/S acquired DYSIS Medical Limited and took over global rights for production, sales, and distribution of DYSIS medical equipment. Apgar had held exclusive rights to market DYSIS in Denmark since 2011, giving them in-depth knowledge of the technology and daily operation. Production continues in Sweden, with new warehouse in Denmark enabling faster delivery across Europe.
- European Federation of Colposcopy (EFC)coreCollaboration on colposcopy training utilizing the colposcopyskills.com platform for online skills development and assessment. DYSIS Medical announced this partnership to provide comprehensive training resources for colposcopists and trainees worldwide.
- ITEM Medical TechnologiescoreSignificant deal to incorporate DYSIS Colposcope into Turkey's national cervical screening programme. ITEM Medical Technologies serves as the distribution partner for this government health initiative.
- Unified Women's Clinical ResearchcoreMulti-center research partnership for computer-aided colposcopy trial. Unified Women's Clinical Research, a subsidiary of Unified Physician Management in Boca Raton, FL, partnered with DYSIS for clinical research collaboration.
- University of KarolinskaminorCollaboration establishing Karolinska as a DYSIS Reference Centre. The prestigious Swedish university installed a DYSIS unit for research and reference purposes.
- duomed (Belgium)standardEuropean distributor for DYSIS products in Belgium
- surgynal (France)standardEuropean distributor for DYSIS products in France
- aenorasis (Greece)standardEuropean distributor for DYSIS products in Greece
- cardiac-services (Ireland)standardEuropean distributor for DYSIS products in Ireland
- DiMed (Italy)standardEuropean distributor for DYSIS products in Italy
- medip (Slovenia)standardEuropean distributor for DYSIS products in Slovenia
- Presurgy (Spain)standardEuropean distributor for DYSIS products in Spain
- Para Medicos (Iraq)standardMiddle East distributor for DYSIS products in Iraq
- TBMedex (Kuwait)standardMiddle East distributor for DYSIS products in Kuwait
- MedESole (Qatar)standardMiddle East distributor for DYSIS products in Qatar
- Morulaa (India)standardAsia distributor for DYSIS products in India
- PT Keanindo (Indonesia)standardAsia distributor for DYSIS products in Indonesia
- QT Instruments (Singapore)standardAsia distributor for DYSIS products in Singapore, part of QT/Biomedia Holdings group
- Southern Skies Medical (Zimbabwe)standardAfrica distributor for DYSIS products in Zimbabwe
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
DYSIS Medical competitors and assessment
Company assessmentDirect peers
- Leisegang Feinmechanik-Optik: German manufacturer of optical colposcopes widely used in gynecology clinics globally. Directly competes with DYSIS's DYSIS View and DYSIS Ultra in the colposcopy equipment category, though Leisegang's products are conventional optical devices without computer-aided spectral imaging.
- CooperSurgical (Wallach): CooperSurgical's Wallach line includes digital and optical colposcopes used in cervical cancer screening. It is the most direct device competitor to DYSIS within a much larger women's health portfolio across IVF, OB/GYN, and surgical instruments.
- Seiler Instrument: Manufactures colposcopes used in cervical cancer screening practices in the US and globally. A traditional optical colposcope competitor without computer-aided spectral imaging but with overlapping customer base in OB/GYN clinics.
Broad incumbents
- Carl Zeiss Meditec: Provides surgical microscopy and colposcopy solutions (e.g., OPMI series) globally as part of a broad ophthalmology, microsurgery, and gynecology imaging portfolio. Overlaps with DYSIS in colposcopy imaging but at a much larger scale and broader clinical scope.
- Hologic: Women's health leader with ThinPrep Pap Test and Genius digital cytology systems for cervical cancer screening. While not a colposcopy device maker, Hologic competes for the same screening budget and downstream colposcopy referral volume that drives DYSIS demand.
- BD (Becton Dickinson): Provides SurePath liquid-based cytology and HPV testing workflows for cervical screening alongside a vast diagnostics portfolio. Competes with DYSIS indirectly by shaping screening paradigms that affect colposcopy volumes.
- QIAGEN: Major HPV molecular testing provider (digene HC2, careHPV) used globally as primary cervical screening. Competes with DYSIS by reducing or redirecting colposcopy referrals through molecular triage rather than adjunctive colposcopic imaging.
- Philips (IntelliSite / Digital Pathology): Philips' IntelliSite Pathology platform and broader medical imaging portfolio overlap with DYSIS's tissue-imaging diagnostic aspiration. While not a direct cervical colposcopy rival, Philips competes for hospital capital budgets and gynecologic diagnostic workflow adoption.
- Roche Diagnostics: Leading HPV testing and cervical cancer diagnostics provider (cobas HPV test) and broader in vitro diagnostics leader. Competes with DYSIS via primary HPV screening and molecular diagnostics that substitute for adjunctive colposcopic imaging.
Emerging players
- MobileODT: Developer of the EVA System, a smartphone-based colposcope with AI image analysis for cervical visual inspection. An emerging low-cost alternative to DYSIS, especially in low-resource settings where smartphone-based screening may displace traditional colposcope hardware.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
DYSIS Medical social profiles
Digital presenceDYSIS Medical compliance and trust
Trust signalCompliance6 records
DYSIS Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
DYSIS Medical leadership team
Management profileNumber of profiles
DYSIS Medical funding detail
Funding detailFunding overview
Funding rounds4 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DYSIS Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DYSIS Medical
What does DYSIS Medical do?
DYSIS Medical develops and sells digital colposcope systems (DYSIS View and DYSIS Ultra) that incorporate proprietary Dynamic Spectral Imaging technology to perform computer-aided cervical mapping. The DYSISmap software quantifies acetowhitening changes during colposcopic examinations and generates a color-coded map to objectively identify areas of potential cervical lesions for biopsy guidance. The product line supports gynecologists, colposcopists, hospitals, and national cervical screening programs in detecting high-grade cervical lesions more reliably than conventional colposcopy.
Is DYSIS Medical a public or private company?
DYSIS Medical is a private company. It is classified as corporate owned and is currently closed.
When was DYSIS Medical founded?
DYSIS Medical was founded in 2002. It employs 11 to 50 people.
Where is DYSIS Medical based?
DYSIS Medical is headquartered in Livingston, United Kingdom, in the Europe region.
How does DYSIS Medical make money?
Three revenue lines are on record. Colposcope Hardware Sales are the primary driver. The others are accessories and Consumables and service and Maintenance.
Who are DYSIS Medical's main competitors?
Direct peers on record are Leisegang Feinmechanik-Optik, CooperSurgical (Wallach) and Seiler Instrument. Broad incumbents are Carl Zeiss Meditec, Hologic, BD (Becton Dickinson), QIAGEN, Philips (IntelliSite / Digital Pathology) and Roche Diagnostics. MobileODT is listed as an emerging player.
Does DYSIS Medical have an API?
No public API is recorded for DYSIS Medical.
What industry is DYSIS Medical in?
DYSIS Medical's product category is Cervical Cancer Diagnostic Imaging Devices. Its primary akta.pro industry code is HLAHAAAE, Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics), with a secondary code of HLAAALAI, Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays). Its NAICS code is 621511 and its SIC code is 3841.